Latest News

drug development in lab | Image credit: Nakron - stock.adobe.com
IQVIA Highlights Opportunity to Cash In on Biosimilars for Biologics Losing Market Exclusivity

November 29th 2023

A report from IQVIA noted that Europe could miss out on €15 billion in cost savings by not having biosimilars for medications about to lose market exclusivity, shedding light on the implications for overall health care savings and ultimately, patient access.

eye on pharma banner
Eye on Pharma: Adalimumab Updates; New Eylea Biosimilar Lawsuit; Canada Gains Stelara Biosimilar

November 22nd 2023

Biosimilar business roundup image
Biosimilars Business Roundup: October 2023

November 1st 2023

Eye on Pharma banner
Eye on Pharma: New GI Data and Byooviz Interchangeability Propel Biosimilars Into the Future

October 25th 2023

guy holding bar graphs
Report: Conflicting Guidelines, Rebate Walls Are Major Factors Determining Biosimilar Uptake

October 24th 2023

Video Interviews
"SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars SEEING EYE TO EYE:  Exploring Different Perspectives on Ophthalmology Biosimilars" with the CfB logo and an image of an eye
CfB podcast banner
CfB podcast banner
CfB podcast banner
Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.